Program_for_print.indd

PROGRAMME
WEDNESDAY 20 NOVEMBER 2013
WEDNESDAY 20 NOVEMBER 2013
8.00-9.00
Clinical Leaders Meeting-SHED 6, ROOM 1
8.30-9.45
Delegate Arrival and Registration
Welcome | President NZSG and NZGNS: A/Prof Alan Fraser and Cathryn Whiteside
9.45-10.00
Convenors: Dr Jeffrey Wong and Cathryn Whiteside
SESSION 1 | General Plenary Session (Joint session)
Chair: A/Prof Alan Fraser and Dr Stephen Inns SHED 6, ROOM 1
10.00-10.30
Achieving quality endoscopy in the UK I Prof Matt Rutter
10.30-11.00
Crohn’s Disease and its Evolution: From Observations to Individualized Therapy I Dr David Rubin
11.00-11.20
Iron and the Liver I Dr Kris Kowdley
11.20-11.40
Quality colonoscopy: To and from the Caecum I Prof Michael Bourke
11.40-12.00
Advancing IBD Nursing in Europe I Marian O’Connor
12.00-1.00
Lunch and Exhibition
SESSION 2 | Endoscopy Quality Improvement Programme
Chair: Dr Tim King SHED 6, ROOM 1
1.00-1.35
The National Endoscopy Quality Improvement Programme I Mr David Theobald and Jenni Masters
SESSION 3 | I BD
SESSION 3A | Upper G I
SESSION 3B | Nurses professional session
Chair: Dr Stephen Inns SHED 6, ROOM 1
Chair: Dr David Rowbotham SHED 6, ROOM 2
Chair: Katherine Broome SHED 6, ROOM 4
Microbiota and faecal transplant
Capsule Endoscopy: The next 5 years
Endoscope Disinfection: Where are
1.40-2.10
1.40-2.10
1.40-2.10
we now? I Di Jones
Host-microbe interactions have
shaped the genetic architecture of
Bravo: Wireless pH monitoring
Knowledge and skills framework
2.10-2.25
2.10-2.25
2.10-2.25
infl ammatory bowel disease
Iron defi ciency in infl ammatory bowel
Genetic Counselling and Gastro
2.25-2.40
2.25-2.40
Impedance I Dr Ian Wilson
2.25-2.40
disease I Dr Melissa Haines
Nurses I Michelle Lau
The role of the infl ammatory bowel
Emerging treatment options for Refl ux
2.40-3.00
2.40-3.00
2.40-3.00
Prison based HCV Clinics I Ying Eu
disease nurse I Marian O’Connor
3.00-3.30
Afternoon Tea
SESSION 4A | Paediatric Gastroenterology:
SESSION 4 | Hepatitis C
SESSION 4B | Nurses professional session cont’d
What Adult Gastroenterologists Need to Know
Chair: Prof Ed Gane SHED 6, ROOM 1
Cha ir: Ying Eu SHED 6, ROOM 4
Chair: Dr Helen Evans SHED 6, ROOM 2
Hepatitis C Treatments: The Next 5
Setting up a Colo-rectal Surgery
3.30-4.00
3.30-3.50
Coeliac Disease I A/Prof Don Cameron
3.30-3.50
Years I Dr Kris Kowdley
Nurse led clinic I Jenny Keene
Who to treat now and who to wait
Stomaltherapy - Getting to the Guts
4.00-4.15
3.50-4.10
Paediatric IBD I Prof Andrew Day
3.50-4.10
of the Matter I Vicky Beban
The Pilot HCV Community Assessment
Transition: What happens when your
Peri-procedural Diabetes Care
4.15-4.30
and Support Programme
4.10-4.30
patients become our patients?
4.10-4.30
The HCV Pilot: Benefi ts for Clinicians Dr
4.30-4.45
4.30-4.40
Questions
4.30-4.40
Questions
4.45-5.00
Questions
5.00-6.00
Welcome Function
7.00-Late
Doctors Dinner and Nurses Dinner
PROGRAMME
THURSDAY 21 NOVEMBER 2013
THURSDAY 21 NOVEMBER 2013
7.00-8.00
The 2nd Annual Great Guts Fun Run (proudly sponsored by AbbVie)
SESSION 5 | Luminal – Free Papers
SESSION 5B | Nurses Free Papers
SESSION 5A | Hepatology – Free Papers
1st Time Presenters
Chair: Dr Jeffrey Wong SHED 6, ROOM 2
SHED 6, ROOM 1
Chair: Jenni Masters SHED 6, ROOM 4
Use of Fibroscan in the assessment
A Silent Illness – Primary Biliary
Osteoprotegerin: a pro-infl ammatory
8.30-8.45
8.30-8.45
of chronic hepatitis B infection
8.30-8.45
Cirrhosis: One Patient’s perspective
role in IBD I Andrew Day
Retrospective comparison of
The Descriptive Epidemiology
Radiofrequency and Microwave
8.45-9.00
of Infl ammatory Bowel Disease in
8.45-9.00
8.45-9.00
Bizarre Bezoars I Katrina Wheatley
ablation for Hepatocellular Carcinoma
Nelson, New Zealand I Darryl Fry
A reduction in FODMAP intake
Tenofovir use in chronic hepatitis B
Reducing polypectomy readmission
correlates strongly with a reduction in
9.00-9.15
9.00-9.15
infection women during pregnancy:
9.00-9.15
rates in Bowel Screening Pilot
IBS symptoms-The FIBS study
Auckland Experience I Judy Huang
Programme I Thelma Turner
Malnutrition Screening in Hospitalised
15 Years of Liver Transplant
Colonoscopy: Supply and Demand
Patients; Laboratory test (Prealbumin)
Assessments for Chronic Liver
9.15-9.30
9.15-9.30
9.15-9.30
at Counties Manukau District Health
versus Routine Clinical Assessment
Disease: A Single Centre Experience
Board I Naomi Reed
The prevalence of abnormal liver
mir-1247 is Down-Regulated in
enzymes in New Zealand: fi ndings
Medication Safety in
9.30-9.45
CpG island Methylator Phenotype
9.30-9.45
9.30-9.45
from the 2008/09 Adult Nutrition
Gastroenterology I Yasmin Reddy
Colorectal Cancers I Jennifer Liang
Survey I Kirsten Coppell
What do endoscopy nurses believe is
Biliary dilatation induced by different
T cell distribution in gastrointestinal
necessary for a Nurse Endoscopist
9.45-10.00
9.45-10.00
opiate drugs – a case series
9.45-10.00
infl ammatory disorders I Elliott Dunn
role to develop in New Zealand?
10.00-10.30
Morning Tea and Exhibition
SESSION 6 | Presidential Young Investigators Free Papers
SESSION 6A | Nurses Free Papers Con’td
Chair: A/Prof Alan Fraser SHED 6, ROOM 1
Chair: Janice Duxfield SHED 6, ROOM 4
Preserved colonic meal response and functional evidence for
Why so slow? Rapid Iron Polymaltose infusions are well tolerated
10.30-10.45
anastomotic nerve regeneration in patients with normal bowel
10.30-10.45
in an outpatient setting I Urmilla Kumar
function following anterior resection I Ryash Vather
Bitter taste receptors within the gastrointestinal tract
Psychological factors and personality traits in Infl ammatory Bowel
10.45-11.00
10.45-11.00
Disease: How to understand our IBD Patients better? I Irit Bialik
Spontaneous maturation of organoids grown from isolated human
Optimise or switch?–What to do when IBD patients fail anti-TNF-
11.00-11.15
11.00-11.15
colonic biopsies I Ely Rodrigues
drugs I Kirsten Rosser
Patient preferences for care in end stage liver disease
Christchurch Hospital Infl ammatory Bowel Disease (IBD) Audit
11.15-11.30
11.15-11.30
Nursing Outcomes I Holly Weale
11.40-12.00
Trans-Tasman Lecture–50 Years of Australian and New Zealand Paediatric Gastroenterology I A/Prof Don Cameron
12.00-13.00
Lunch and Exhibition & Formal Poster Round–Poster Judging
SESSION 7 | Colon Cancer in IBD
SESSION 7A | Nurses AGM
SESSION 7B | RACP – Adult Medicine
Chair: A/Prof Richard Gearry SHED 6, ROOM 1
Chair: Cathryn Whiteside SHED 6, ROOM 4
Young Investigators Awards SHED 6, ROOM 2
Update in Colorectal Cancer in
Colitis: Towards an Individualized
Prevalence of autoantibodies in
1.00-1.20
Approach
idiopathic infl ammatory myopathy and/
or interstitial pneumonia
Dr Rama Kalluru
Surveillance in IBD: The State of the
1.20-1.40
Art I Prof Matt Rutter
Inhibition of 5-reductase type 1 with
dutasteride in men increases body fat
Reducing Colon Cancer Risk with
1.00-2.30
1.00-2.30
and impairs insulin sensitivity
1.40-2.00
Drugs I A/Prof Michael Schultz
Surgery for Cancer in IBD
Diagnosis of myocardial infarction after
2.00-2.20
coronary artery bypass grafting with
high-sensitivity troponin: validation of
the universal defi nition
2.20-2.30
Discussion
2.30-3.00
Afternoon Tea and Exhibition
PROGRAMME
THURSDAY 21 - FRIDAY 22 NOVEMBER 2013
SESSION 8 | Colonoscopy
SESSION 8A | Liver Cancer
SESSION 8B | Nurse Professional Session
Chair: Dr Michael Burt SHED 6, ROOM 1
Chair: Dr Richard Stein SHED 6, ROOM 2
Chair: Kirsten Rosser SHED 6, ROOM 4
Advanced Polypectomy in the Colon
Hepatocellular Carcinoma in New
IBD for Endoscopy Nurses
3.00-3.30
3.00-3.20
3.00-3.30
Zealand I Prof Ed Gane
What are the important KPI’s
Diagnosis and staging of HCC in 2013
Nurses Role in Endoscopy Quality
3.30-3.50
3.20-3.40
3.30-3.45
Improvement I Jenni Masters
Colonic Tatooing
Standards for Endoscopic Facilities
3.50-4.00
3.40-4.00
Surgery for HCC I Mr Adam Bartlett
3.45-4.00
and Services I Di Jones
SESSION 9 | Oral poster presentations (5x5min slots-3 slide poster
SESSION 9A | Advanced ER in the UGIT
presentations) Chair: Dr Stephen Inns SHED 6, ROOM 1
Chair: Dr Rees Cameron SHED 6, ROOM 2
Faecal S100A12 in healthy infants and children I Andrew Day
Colorectal Cancer After Colonoscopy: Risk Factors And
Survival Data Compared With Cancer Diagnosed At Time Of
Colonoscopy I Nathan Atkinson
Infl ammatory bowel disease patient preferences for a
computerised over face-to-face psychological intervention
4.05-4.30
4.05-4.30
Video Cases I Prof Michael Bourke
CAPER score as a prioritization tool for colonoscopy grading in
colorectal cancer investigation in Bay of Plenty DHB
Judy Huang
Infl ammatory Bowel Disease Mortality in Canterbury, New
Zealand I A Forbes
4.30-6.00
NZSG AGM I SHED 6, ROOM 2
7.00-Late
Conference Dinner I The Renouf Foyer, Michael Fowler Centre, Wellington I Bilbo goes to the Sevens
FRI DAY 22 NOVEMBER 2013
SESSION 10 | General Hepatology
SESSION 10A | Nurses Hands on Session
Chair: Dr Stephen Gerred SHED 6, ROOM 1
Chair: Katherine Broome SHED 6, ROOM 4
9.00-9.30
Non Alcholic fatty liver Disease I Dr Kris Kowdley
9.30-10.00
An Update on Hepatitis B In New Zealand I Prof Ed Gane
Gastroenterologists role in the care of the patient with a Liver
10.00-10.30
transplant I Dr Dominic Ray-Chaudhuri
10.30-11.00
Morning Tea and Exhibition
SESSION 11 | General Session (Joint Session)
Chair: Dr Richard Stein SHED 6, ROOM 1
11.00-11.20
Colonoscopy Services Across New Zealand I A/Prof Susan Parry
11.20-11.40
Nurse Endoscopy in Australia I Di Jones
11.40-12.00
Population Colon Cancer Screening: How to achieve equity I A/Prof Diana Sarfati
12.00-12.15
Closing Remarks
12.15-1.15
NB: Prelim Programme is subject to change without notice

Source: http://www.gastro2013.co.nz/downloads/Programme_Nov13.pdf